|
DAXX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.115700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.781600E-01 |
| Normal-vs-Stage2 |
4.391000E-01 |
| Normal-vs-Stage3 |
2.383100E-03 |
| Normal-vs-Stage4 |
1.311820E-02 |
| Stage1-vs-Stage2 |
6.665600E-01 |
| Stage1-vs-Stage3 |
3.316000E-03 |
| Stage1-vs-Stage4 |
1.021130E-03 |
| Stage2-vs-Stage3 |
2.106200E-02 |
| Stage2-vs-Stage4 |
1.714450E-02 |
| Stage3-vs-Stage4 |
7.579400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.507500E-02 |
| Normal-vs-AfricanAmerican |
4.977700E-02 |
| Normal-vs-Asian |
1.455360E-01 |
| Caucasian-vs-AfricanAmerican |
4.231000E-01 |
| Caucasian-vs-Asian |
5.456800E-01 |
| AfricanAmerican-vs-Asian |
7.617000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.890190E-01 |
| Normal-vs-Female |
3.703200E-03 |
| Male-vs-Female |
1.482110E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.724100E-02 |
| Normal-vs-Extreme_Weight |
6.246000E-01 |
| Normal-vs-Obese |
6.583200E-03 |
| Normal-vs-Extreme_Obese |
5.495000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.608650E-01 |
| Normal_Weight-vs-Obese |
4.034200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.495840E-01 |
| Extreme_Weight-vs-Obese |
1.263570E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.643000E-01 |
| Obese-vs-Extreme_Obese |
6.376000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.715500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.781100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.281000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.937200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.701800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.262590E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.097400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.516900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.935700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.654400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.703700E-02 |
| Normal-VS-Type2 PRCC |
6.319600E-01 |
| Normal-VS-KIRP CIMP |
8.437800E-03 |
| Normal-VS-Unclassified PRCC |
4.592800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.930230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.297600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.928600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.637600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.198400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.962900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.042200E-01 |
| Normal-vs-N1 |
8.18810000000614E-05 |
| Normal-vs-N2 |
8.088600E-01 |
| N0-vs-N1 |
5.89439999999497E-05 |
| N0-vs-N2 |
7.828400E-01 |
| N1-vs-N2 |
5.968700E-04 |
|
|
